Naoto Morikawa

Targeting DNA Damage Response Promotes Antitumor Immunity through STING-Mediated T-cell Activation in Small Cell Lung Cancer

Triparna Sen, B. Leticia Rodriguez, Limo Chen et al. · Cancer Discovery · 2019 · 841 citations · Full text

Prospective Phase II Study of Gefitinib for Chemotherapy-Naïve Patients With Advanced Non–Small-Cell Lung Cancer With Epidermal Growth Factor Receptor Gene Mutations

Akira Inoue, Takuji Suzuki, Tatsuro Fukuhara et al. · Journal of Clinical Oncology · 2006 · 503 citations · Full text

First-Line Gefitinib in Patients Aged 75 or Older With Advanced Non–Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations: NEJ 003 Study

Makoto Maemondo, Yuji Minegishi, Akira Inoue et al. · Journal of Thoracic Oncology · 2012 · 154 citations

Patients Aged 75, Medicine, First-line Gefitinib +9

Successful Treatment of Carcinomatous Meningitis with Gefitinib in a Patient with Lung Adenocarcinoma Harboring a Mutated EGF Receptor Gene

Tatsuro Fukuhara, Yasuo Saijo, Tomohiro Sakakibara et al. · The Tohoku Journal of Experimental Medicine · 2008 · 37 citations · Full text

Carcinomatous Meningitis, Successful Treatment, Medicine +12

Randomized phase II trial comparing amrubicin with re-challenge of platinum doublet in patients with sensitive-relapsed small-cell lung cancer: North Japan Lung Cancer Study Group trial 0702

Akira Inoue, Shunichi Sugawara, Makoto Maemondo et al. · Lung Cancer · 2015 · 34 citations

Platinum Doublet, Phase Ii Trial, Medicine +7